
Health Dictionary
Reliable, easy-to-read patient information on common medical conditions — written in plain language, free of jargon, and grounded in current evidence. Browse the most frequent diagnoses, understand what they mean for everyday life, and learn which steps and questions help you have a focused conversation with your doctor.
Gastritis causes
Introduction
Overview
Overview
Gastritis is gastric mucosal injury accompanied by a significant inflammatory infiltrate. Gastropathy is epithelial or mucosal injury with little or no inflammation, as seen in chemical (reactive) injury from NSAIDs or bile.[1] Current classification is based on cause, as set out in the Kyoto Global Consensus and the Real-World Gastritis Initiative (RE.GA.IN.).[2][3]
- Helicobacter pylori infection is the leading cause of chronic gastritis worldwide.
- Autoimmune gastritis is the main non-infectious cause of corpus-restricted atrophic gastritis.
- Reactive (chemical) gastropathy from NSAIDs, aspirin, or bile reflux is the most frequent diagnosis where H. pylori is uncommon.
Less common causes include:
- Lymphocytic, eosinophilic, granulomatous, and collagenous gastritis
- Non–H. pylori infections, mainly in immunocompromised hosts
- Radiation, caustic, and ischemic injury
Causes
Causes
Life-Threatening Causes
Life-threatening causes are conditions that can lead to death or permanent disability within 24 hours if left untreated.
- Phlegmonous gastritis and its gas-forming variant, emphysematous gastritis: bacterial infection of the gastric wall with mortality of approximately 40%.[4]
- Caustic or corrosive ingestion (acids, alkalis)[1]
- Stress-related mucosal disease in critical illness, major surgery, burns, or trauma. This is an erosive, ischemia- and acid-mediated gastropathy, not true inflammatory gastritis.
- Cytomegalovirus (CMV) and other opportunistic infections in immunocompromised patients, which can present as ulceration with bleeding[4]
Common Causes
- H. pylori infection[5]
- Autoimmune gastritis[6]
- NSAIDs and aspirin, which cause reactive gastropathy[1]
- Bile (duodenogastric) reflux[7]
Causes by Etiologic Category
Helicobacter pylori Infection
- H. pylori is the most common cause of chronic gastritis worldwide and is a WHO/IARC group 1 carcinogen.[5]
- It colonizes approximately 43% of the world population.
- Infection is usually acquired in childhood and persists for life if untreated.
- It produces chronic active gastritis, which stays asymptomatic for decades in most carriers.[5]
- Phenotype depends on topography:[5][8]
- Antral-predominant gastritis: acid output preserved or high; predisposes to duodenal ulcer.
- Corpus-predominant gastritis or pangastritis: acid output reduced; predisposes to gastric ulcer, atrophy, and gastric adenocarcinoma.
- Bacterial virulence factors are the main determinants of inflammatory intensity and cancer risk. These are a functional cag pathogenicity island (CagA) and the vacuolating cytotoxin VacA.[5]
- Long-standing infection drives the Correa cascade:[9]
- Non-atrophic gastritis → multifocal atrophic gastritis → intestinal metaplasia → dysplasia → adenocarcinoma.
- The rate ratio for atrophic gastritis in infected versus uninfected persons is approximately 5.0.
- Atrophy incidence in uninfected persons is below 1% per year.
- Helicobacter heilmannii is a less common cause of Helicobacter gastritis.[4]
Autoimmune Gastritis
- Autoimmune gastritis (AIG) is immune-mediated destruction of parietal (oxyntic) cells.[6][10]
- It is restricted to the corpus and fundus and spares the antrum, which is the reverse of most H. pylori gastritis.
- It is not self-limiting.
- Mechanism:[6]
- The gastric H+/K+ ATPase (proton pump) is the major autoantigen.
- Autoreactive T cells drive parietal cell loss.
- Anti-parietal cell antibodies (PCA) and anti-intrinsic factor antibodies (IFA) are produced.
- Consequences are hypo- or achlorhydria, loss of intrinsic factor, and hypergastrinemia. These lead to malabsorption of:[11][12]
- Iron, causing iron-deficiency anemia (often the earlier presentation, in younger patients)
- Vitamin B12, causing pernicious anemia (a later presentation, in older patients)
- Folate and calcium
- AIG accounts for approximately 20–27% of obscure or refractory iron-deficiency anemia.[12]
- Pernicious anemia is a late complication of AIG, not a synonym for it.[10]
- Other complications are type 1 gastric neuroendocrine tumors and increased gastric adenocarcinoma risk.[6][13]
- Epidemiology:[9]
- Estimated prevalence is approximately 0.5–2% and rises with age.
- Women are more often affected.
- AIG is strongly associated with autoimmune thyroid disease (up to about one-third of these patients have AIG) and type 1 diabetes mellitus.
- Racial and ethnic variation is less prominent than in H. pylori-associated atrophic gastritis.
- Potential and seronegative AIG are now recognized variants.[10]
- H. pylori may trigger AIG through molecular mimicry, but this has not been proven.[6][14]
Reactive (Chemical) Gastropathy
Histologic features are:[15][1]
- Foveolar hyperplasia (“corkscrew” glands)
- Lamina propria edema
- Smooth muscle fibers extending into the lamina propria
- Vascular ectasia
- Minimal inflammation
It is the most common histopathologic gastric change in large US biopsy cohorts, and its prevalence rises with age.[16]
Causes:
- NSAIDs and aspirin are the most common medication cause.[1][17]
- Reactive gastropathy is found in up to approximately 45% of regular NSAID users.
- Injury comes from direct topical damage (independent of prostaglandins) plus cyclooxygenase inhibition, and acid makes it worse.
- Bile (duodenogastric) reflux:[7][18]
- In the intact stomach, it injures the antrum.
- After partial gastrectomy or gastrojejunostomy (Billroth II), it injures the corpus and anastomosis and contributes to gastric stump cancer.
- Other drugs and agents:[15]
- Bisphosphonates
- Oral iron
- Tetracyclines, especially doxycycline
- 5-aminosalicylic acid
- Antiplatelet agents such as clopidogrel
- Selective serotonin reuptake inhibitors
- Alcohol[19]
- Gastrostomy tubes can cause localized reactive injury.[15]
Other Non-Infectious Gastritides
- Lymphocytic gastritis is associated with celiac disease and H. pylori. Some cases are drug-induced or idiopathic.[1][20]
- Eosinophilic gastritis is linked to food or allergic sensitization and other allergic mechanisms.[1]
- Granulomatous gastritis:[1]
- Leading identifiable causes are Crohn’s disease and sarcoidosis.
- Other causes are foreign material and granulomatosis with polyangiitis.
- Some cases are idiopathic (isolated granulomatous gastritis).
- Collagenous gastritis is rare. Its cause is unknown and may be autoimmune.[1]
Non–H. pylori Infectious Gastritis
These infections occur mostly in immunocompromised hosts: HIV, transplant, chemotherapy, high-dose corticosteroids, diabetes mellitus, and malnutrition.[7][4]
- Viral:[4]
- CMV is the most common, with characteristic “owl-eye” inclusions.
- Herpes simplex virus involves the stomach rarely and causes punched-out ulcers.
- Bacterial (non–H. pylori):[4]
- Phlegmonous gastritis is caused by Streptococcus, Escherichia coli, Enterobacter, or Proteus.
- Risk factors are immunosuppression, diabetes, alcoholism, hypochlorhydria, and recent instrumentation.
- Emphysematous gastritis is the gas-forming variant.
- Other bacterial causes are mycobacteria, syphilis, and Salmonella.
- Phlegmonous gastritis is caused by Streptococcus, Escherichia coli, Enterobacter, or Proteus.
- Fungal and parasitic:[1][4]
- Fungi: Candida, mucormycosis, histoplasmosis, aspergillosis
- Parasites: anisakiasis, strongyloidiasis
- These occur mainly with immunocompromise or exposure in endemic areas.
Physical, Caustic, and Ischemic Injury
- Radiation therapy to the upper abdomen causes radiation gastropathy.[1]
- Ingestion of caustic or corrosive agents (acids, alkalis) or other chemical irritants causes direct injury.[1]
- Gastric hypoperfusion and stress-related mucosal disease are erosive gastropathies, not inflammatory gastritis.
Etiologic Cofactors
These factors modify disease rather than cause it on their own.
- Tobacco and high-salt diet are cofactors for non-autoimmune atrophic gastritis and accelerate H. pylori-associated atrophy.[9][21]
- Alcohol contributes to reactive gastropathy.[19]
- Coffee, acidic beverages, and spicy or fatty foods may provoke dyspeptic symptoms. They are not established causes of histologic gastritis in current classifications.[3]
Summary of Etiologic Categories
| Category | Principal causes | Typical pattern | Key association |
|---|---|---|---|
| H. pylori | H. pylori; rarely H. heilmannii | Chronic active gastritis; antral-predominant or multifocal atrophy | Peptic ulcer; gastric adenocarcinoma; MALT lymphoma |
| Autoimmune | Anti-parietal cell immunity (H+/K+ ATPase) | Corpus-restricted atrophy with antral sparing | Iron or B12 deficiency; type 1 gastric NET; thyroid disease and type 1 diabetes |
| Reactive gastropathy | NSAIDs/aspirin, bile reflux, bisphosphonates, iron, doxycycline, alcohol | Foveolar hyperplasia with minimal inflammation | Remove the offending agent; not an infection |
| Other non-infectious | Celiac disease, allergy, Crohn’s disease, sarcoidosis | Lymphocytic, eosinophilic, granulomatous, or collagenous patterns | Systemic disease outside the stomach |
| Non–H. pylori infectious | CMV, HSV, phlegmonous bacteria, fungi, parasites | Ulcers or erosions; mural infection | Immunocompromise; phlegmonous form carries ~40% mortality |
| Physical/caustic/ischemic | Radiation, caustic ingestion, hypoperfusion, critical illness | Erosive gastropathy | Emergency presentations |
References
References
- ↑ 1.00 1.01 1.02 1.03 1.04 1.05 1.06 1.07 1.08 1.09 1.10 1.11 Washington MK, Peek RM (2022). “Gastritis and gastropathy”. Yamada’s Textbook of Gastroenterology (7th ed.).
- ↑ 2.0 2.1 Sugano K, Tack J, Kuipers EJ; et al. (2015). “Kyoto global consensus report on Helicobacter pylori gastritis”. Gut. 64 (9): 1353–67. doi:10.1136/gutjnl-2015-309252. PMID 26187502.
- ↑ 3.0 3.1 Rugge M, Genta RM, Malfertheiner P; et al. (2024). “RE.GA.IN.: the Real-world Gastritis Initiative—updating the updates”. Gut. 73 (3): 407–441. doi:10.1136/gutjnl-2023-331164. PMID 38383142 Check
|pmid=value (help). - ↑ 4.0 4.1 4.2 4.3 4.4 4.5 4.6 Panarelli NC (2021). “Infectious diseases of the upper gastrointestinal tract”. Histopathology. 78 (1). PMID 33382485 Check
|pmid=value (help). - ↑ 5.0 5.1 5.2 5.3 5.4 Malfertheiner P, Camargo MC, El-Omar E, Liou JM, Peek R, Schulz C, Smith SI, Suerbaum S (2023). “Helicobacter pylori infection”. Nat Rev Dis Primers. 9 (1): 19. doi:10.1038/s41572-023-00431-8. PMID 37081005 Check
|pmid=value (help). - ↑ 6.0 6.1 6.2 6.3 6.4 Lenti MV, Rugge M, Lahner E, Miceli E, Toh BH, Genta RM, De Block C, Hershko C, Di Sabatino A (2020). “Autoimmune gastritis”. Nat Rev Dis Primers. 6 (1): 56. doi:10.1038/s41572-020-0187-8. PMID 32647173 Check
|pmid=value (help). - ↑ 7.0 7.1 7.2 El-Zimaity H, Choi WT, Lauwers GY, Riddell R (2018). “The differential diagnosis of Helicobacter pylori negative gastritis”. Virchows Arch. 473 (5): 533–550. doi:10.1007/s00428-018-2454-8. PMID 30229307.
- ↑ Suerbaum S, Michetti P (2002). “Helicobacter pylori infection”. N Engl J Med. 347 (15): 1175–86. doi:10.1056/NEJMra020542. PMID 12374879.
- ↑ 9.0 9.1 9.2 Shah SC, Piazuelo MB, Kuipers EJ, Li D (2021). “AGA Clinical Practice Update on the Diagnosis and Management of Atrophic Gastritis: Expert Review”. Gastroenterology. 161 (4): 1325–1332.e7. doi:10.1053/j.gastro.2021.06.078. PMID 34454714 Check
|pmid=value (help). - ↑ 10.0 10.1 10.2 Lenti MV, Miceli E, Vanoli A, Di Sabatino A (2026). “Autoimmune gastritis: emerging insights and clinical management”. Nat Rev Gastroenterol Hepatol.
- ↑ Toh BH (2017). “Pathophysiology and laboratory diagnosis of pernicious anemia”. Immunol Res. 65 (1): 326–330. doi:10.1007/s12026-016-8841-7. PMID 27538411.
- ↑ 12.0 12.1 Bergamaschi G, Di Sabatino A, Corazza GR (2018). “Pathogenesis, diagnosis and treatment of anaemia in immune-mediated gastrointestinal disorders”. Br J Haematol. 182 (3): 319–329. doi:10.1111/bjh.15254.
- ↑ Kishikawa H, Nakamura K, Ojiro K, Katayama T, Arahata K, Takarabe S; et al. (2022). “Relevance of pepsinogen, gastrin, and endoscopic atrophy in the diagnosis of autoimmune gastritis”. Sci Rep. 12 (1): 4202. doi:10.1038/s41598-022-07947-1. PMID 35273265 Check
|pmid=value (help). - ↑ 14.0 14.1 Rugge M, Savarino E, Sbaraglia M, Bricca L, Malfertheiner P (2021). “Gastritis: the clinico-pathological spectrum”. Dig Liver Dis. 53 (10): 1237–1246. doi:10.1016/j.dld.2021.03.007. PMID 33785282 Check
|pmid=value (help). - ↑ 15.0 15.1 15.2 El-Zimaity H, Riddell RH (2021). “Beyond Helicobacter: dealing with other variants of gastritis—an algorithmic approach”. Histopathology.
- ↑ Maguilnik I, Neumann WL, Sonnenberg A, Genta RM (2012). “Reactive gastropathy is associated with inflammatory conditions throughout the gastrointestinal tract”. Aliment Pharmacol Ther. 36 (8): 736–43. doi:10.1111/apt.12031. PMID 22928604.
- ↑ Laine L (1996). “Nonsteroidal anti-inflammatory drug gastropathy”. Gastrointest Endosc Clin N Am. 6 (3): 489–504. PMID 8803564.
- ↑ Nakamura M, Haruma K, Kamada T, Mihara M, Yoshihara M, Imagawa M; et al. (2001). “Duodenogastric reflux is associated with antral metaplastic gastritis”. Gastrointest Endosc. 53 (1): 53–9. doi:10.1067/mge.2001.111385. PMID 11154489.
- ↑ 19.0 19.1 Franke A, Teyssen S, Singer MV (2005). “Alcohol-related diseases of the esophagus and stomach”. Dig Dis. 23 (3–4): 204–13. doi:10.1159/000090167. PMID 16508284.
- ↑ Varbanova M, Frauenschläger K, Malfertheiner P (2014). “Chronic gastritis—an update”. Best Pract Res Clin Gastroenterol. 28 (6): 1031–42. doi:10.1016/j.bpg.2014.10.005. PMID 25439069.
- ↑ Nakamura M, Haruma K, Kamada T, Mihara M, Yoshihara M, Sumioka M; et al. (2002). “Cigarette smoking promotes atrophic gastritis in Helicobacter pylori-positive subjects”. Dig Dis Sci. 47 (3): 675–81. PMID 11911358.
Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1]; Associate Editor(s)-in-Chief: Fahad Hasan, M.D.[2] Aravind Reddy Kothagadi M.B.B.S[3]
